BioCentury
ARTICLE | Clinical News

JX-594: Phase IIa started

January 2, 2012 8:00 AM UTC

Jennerex began an open-label, Canadian Phase IIa trial to evaluate intratumoral and IV JX-594 in about 20 patients with colorectal cancer metastases in the liver who are undergoing liver resection...